Abstract
The systemic vasculitides are a diverse set of immunologically mediated disorders that share certain constitutional features, described clinically as the vasculitic syndrome, and that are distinguished by unique complexes of focal symptoms and signs of inflammation and vascular pathology. Several comprehensive monographs (1–4), textbook chapters (5–8), and review articles (9–12) on the clinical and pathological aspects of systemic and renal vasculitis have been published in the past several years. Patients with systemic vasculitis tend to segregate among medical specialties according to the major organ system involvement, and each specialty creates its own classification system. Disciplines vary in their preferences for the lumping and splitting of vasculitic diseases. Proposals for standardization of criteria for diagnosis and classification of systemic vasculitis have recently appeared (13,14).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Churg A, Churg J: Systemic Vasculitides. Igaku-Shoin, New York, pp 1–389, 1991.
Cupps TR, Fauci AS: The Vasculitides. WB Saunders, Philadelphia, pp 1–211, 1981.
LeRoy EC, ed: Systemic Vasculitis: The Biological Basis Marcel Dekker, New York, pp 1–583, 1992.
Sessa A, Meroni M, Battini G: Renal involvement in systemic vasculitis. Contrib Nephrol 94: 1–205, 1991.
Balow JE, Fauci AS: Vasculitic diseases of the kidney. In: RW Schrier, CW Gottschalk, eds, Diseases of the Kidney, 61h ed. Little, Brown, Boston, pp 1851–1878, 1997.
Fauci AS, Leavitt RY: Vasculitis. In: DJ McCarty, WJ Koopman, eds, Arthritis and Allied Conditions: A Textbook of Rheumatology, 12th ed. Lea & Febiger, Philadelphia, pp 1301–1302, 1993.
Gaskin G, Pusey CD: Systemic vasculitis. In: JS Cameron, AM Davison, JP Grunfeld, D Kerr, E Ritz, eds, Oxford Textbook of Clinical Nephrology. Oxford University Press, Oxford, pp 612–636, 1992.
Spargo BH, Seymour AE, Ordenez NG: Vasculitis. In: Renal Biopsy Pathology with Diagnostic and Therapeutic Implications. Wiley, New York, pp 205–218, 1980.
Balow JE: Renal vasculitis. Curr Opin Nephrol Hypertens 2: 231–237, 1993.
Cameron JS: The long-term outcome of glomerular diseases. In: RW Schrier, CW Gottschalk, eds, Diseases of the Kidney, 6th ed. Little, Brown, Boston, pp 1919–1981, 1997.
Conn DL: Polyarteritis. Rheum Dis Clin North Am 16: 34 1362, 1990.
Falk RJ: ANCA-associated renal disease. Kidney Int 38: 998 1010, 1990.
Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Michel BA, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ: The American College of Rheumatology 1990 Criteria for the classification of vasculitis. Introduction. Arthritis Rheum 33: 1065–1067, 1990.
Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al.: Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37: 187–192, 1994.
Angangco R, Thiru S, Esnault VLM, Short AK, Lockwood CM, Oliveira DBG: Does truly “idiopathic” crescentic glomerulonephritis exist? Nephrol Dial Transplant 9: 630636, 1994.
Falk RJ, Hogan S, Carey TS, Jennette JC: Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 113: 656–663, 1990.
Jennette JC, Falk RJ: The pathology of vasculitis involving the kidney. Am J Kidney Dis 24: 130–141, 1994.
Velosa JA: Idiopathic crescentic glomerulonephritis or systemic vasculitis? Mayo Clin Proc 62: 145–147, 1987.
Mathieson PW, Qasim FJ, Esnault VLM, Oliveira DBG: Animal models of systemic vasculitis. J Autoimmunol 6: 25 1264, 1993.
Balow JE: Renal vasculitis. Kidney Int 27: 954–964, 1985.
Fauci AS, Haynes BF, Katz P: The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 89: 660–676, 1978.
D’Agati V, Chander P, Nash M, Mancilla-Jimenez R: Idiopathic microscopic polyarteritis nodosa: ultrastructural observations on the renal vascular and glomerular lesions. Am J Kidney Dis 7: 95–110, 1986.
Davies DJ, Moran JE, Niall JF, Ryan GB: Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J 285: 606, 1982.
van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1: 425–429, 1985.
Golden MP, Hammer SM, Wanke CA, Albrecht MA: Cytomegalovirus vasculitis. Case report and review of the literature. Medicine (Baltimore) 73: 246–255, 1994.
Sergent JS: Vasculitides associated with viral infections. Clin Rheum Dis 6: 339, 1980.
Kallenberg CG, Brouwer E, Weening JJ, Cohen Tervaert JW: Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiologic potential. Kidney Int 46: 1–15, 1994.
Ewert BH, Jennette JC, Falk RJ: Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 41: 375–383, 1992.
Falk RJ, Terrell R, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals. Proc Nall Acad Sci USA 87: 4115–4119, 1990.
Jennette JC, Tuttle R, Falk RJ: The clinical, serologic, and immunopathologic heterogeneity of cutaneous leukocytoclastic angiitis. Adv Exp Med Biol 336: 323–326, 1993.
Hellman DB, Laing TJ, Petri M, Whiting-O’Keefe Q, Parry GJ: Mononeuritis multiplex: the yield of evaluations for occult rheumatic diseases. Medicine (Baltimore) 67: 145–53, 1988.
Camillieri M, Pusey CD, Chadwick VS, Rees AJ: Gastrointestinal manifestations of systemic vasculitis. Q J Med 52: 141–149, 1983.
Albert DA, Rimon D, Silverstein MD: The diagnosis of polyarteritis nodosa. I. A literature-based decision analysis approach. Arthritis Rheum 31: 1117–1127, 1988.
Ewald EA, Griffin D, McCune WJ: Correlation of angiographic abnormalities with disease manifestations and
disease severity in polyarteritis nodosa. J Rheumatol 145: 952–956, 1987.
Dahlberg PJ, Lockhart JM, Overholt EL: Diagnostic studies for systemic necrotizing vasculitis. Arch Intern Med 149: 16 1165, 1989.
Hekali P, Kajander H, Pajari R, Stenman S, Somer T: Diagnostic significance of angiographically observed visceral aneurysms with regard to polyarteritis nodosa. Acta Radiol 32: 143–148, 1991.
Travers RL, Allison DJ, Brettle RP, Hughes GRV: Polyarteritis nodosa: a clinical and angiographic analysis of 17 cases. Semin Arthritis Rheum 8: 184–199, 1979.
Cohen RD, Conn DL, Ilstrup DM: Clinical features, prognosis and response to treatment in polyarteritis. Mayo Clin Proc 55: 146–155, 1980.
Leib ES, Hibrawi H, Chia D, Blaker RG, Barnett EV: Correlation of disease activity in systemic necrotizing vasculitis with immune complexes. J Rheumatol 8: 258–265, 1981.
Sack M, Cassidy JT, Bole GG: Prognostic factors in polyarteritis. J Rheumatol 2: 411–420, 1975.
Savage CO, Winearls CG, Evans DJ, Rees Ai, Lockwood CM: Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 56: 467–483, 1985.
Serra A, Cameron JS, Turner DR, Hartley B, Ogg CS, Neild GH, Williams DG, Taube D, Brown CB, Hicks JA: Vasculitis affecting the kidney: presentation histopathology and long-term outcome. Q J Med 53: 181–207, 1984.
Frohnert PP, Sheps SG: Long-term follow-up study of periarteritis nodosa. Am J Med 43: 8–14, 1967.
Dayson J, Ball J, Platt R: The kidney in periarteritis nodosa. Q J Med 17: 175–202, 1948.
Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic auto-antibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318: 1651–1657, 1988.
Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, The TH, von dem Borne AEG, Kallenberg CGM: Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 37: 799–806, 1990.
Adu D, Howie AJ, Scott DGI, Bacon PA, McGonigle RJS, Michael J: Polyarteritis and the kidney. Q J Med 62: 221–237, 1987.
Coward RA, Hamdy NAT, Shortland JS, Brown CB: Renal polyarteritis: a treatable condition. Nephrol Dial Transplant 1: 31–37, 1986.
Fuiano G, Cameron JS, Raftry M, Hartley BH, Williams DG, Ogg CS: Improved prognosis of renal polyarteritis in recent years. Nephrol Dial Transplant 3: 383–391, 1988.
Gaskin G, Savage CO, Ryan JJ, Jones S, Rees AJ, Lockwood CM, Pusey CD: Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 6: 689–694, 1991.
Wilkowski MJ, Velosa JA, Holley KE, Offord KP, Chu C-P, Torres VE, McCarthy JT, Donadio JV Jr, Wagoner RD: Risk factors in idiopathic renal vasculitis and glomerulonephritis. Kidney Int 36: 1133–1141, 1989.
Churg J: Nomenclature of vasculitic syndromes: a historical perspective. Am J Kidney Dis 18: 148–153, 1991.
Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes DM, Peel AC, Wood JB: Wegener’s granuloma: a series of 265 British cases seen between 1975 and 1985. Q J Med 83: 427–438, 1992.
Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76–85, 1983.
Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116: 488498, 1992.
Woodworth TG, Abuelo JG, Austin HA III, Esparza A: Severe glomerulonephritis with late emergence of classic Wegener’s granulomatosis. Medicine (Baltimore) 66: 18 1191, 1987.
Kerr GS, Fleischer TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS.: Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener’s granulomatosis. Arthritis Rheum 36: 365–371, 1993.
Bindi P, Mougenot B, Mentre F, Noel LH, Peraldi MN, Vanhille P, Lesavre P, Mignon F, Ronco PM: Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. Q J Med 86: 55–68, 1993.
Ferrario F, Tadros MT, Napodano P, Sinico RA, Fellin G, D’Amico G: Critical re-evaluation of “idiopathic” crescentic glomerulonephritis. Clin Nephrol 41: 1–9, 1994.
Pusey CD, Lockwood CM: Autoimmunity in rapidly progressive glomerulonephritis. Kidney Int 35: 929–937, 1989.
Fauci AS, Katz P, Haynes BF, Wolff SM: Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 301: 235–238, 1979.
Guillevin L, Fain O, Lhote F, Jarrouse B, Le Thi Huong D, Bussel A, Leon A: Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. Arthritis Rheum 35: 208–215, 1992.
Fort JG, Abruzzo JL: Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisolone. Arthritis Rheum 31: 1194–1198, 1988.
Jayne DRW, Davies MJ, Fox CJV, Black CM, Lockwood CM: Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 337: 1137–1139, 1991.
Tuso P, Moudgil A, Hay J, Goodman D, Kamil E, Koyyana R, Jordan SC: Treatment of antineutrophil cytoplasmic autoantibody-positive systemic vasculitis and glomerulonephritis with pooled intravenous gammaglobulin. Am J Kidney Dis 20: 504–508, 1992.
Lockwood CM, Thiru S, Isaacs JD, Hale G, Waldmann H: Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet 341: 1620–1622, 1993.
Mathieson PW, Cobbold SP, Hale G, Clark MR, Oliviera DGB, Lockwood CM, Waldmann H: Monoclonal antibody therapy in systemic vasculitis. N Engl J Med 323: 250–254, 1990.
Guillevin L, Llote F, Sauvaget F, Rossi F, Levallois D, Pourrat J, Christoforov B, Trepo C: Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 53: 334337, 1994.
Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS: Surgical pathology of the lung in Wegener’s granulomatosis. Am J Surg Pathol 15: 315–333, 1991.
Bosch X, Mirapeix E, Font J, Cervera R, Ingelmo M, Khamashta MA, Revert L, Hughes GRV, Urbano-Marquez A: Anti-myeloperoxidase autoantibodies in patient with necrotizing glomerular and alveolar capillaritis. Am J Kidney Dis 20: 231–239, 1992.
Haworth SJ, Savage CO, Carr D, Hughes JMB, Rees AJ: Pulmonary hemorrhage complicating Wegener’s granulomatosis and microscopic polyarteritis. Br Med J 290: 1775 1778, 1985.
Imoto EM, Lombard CM, Sachs DP: Pulmonary capillaritis and hemorrhage: a clue to the diagnosis of systemic necrotizing vasculitis. Chest 96: 927–928, 1989.
Cupps TR: Cyclophosphamide: to pulse or not to pulse? Am J Med 89: 399–402, 1990.
Hoffman GS, Leavitt RY, Fleischer TA, Minor JR, Fauci AS: Treatment of Wegener’s granulomatosis with intermittent high dose intravenous cyclophosphamide. Am J Med 89: 403410, 1990.
Genereau T, Lortholary O, Leclerq P, Grenet D, Tubery M, Sicard D, Caubarrere I, Guillevin L: Treatment of systemic vasculitis with cyclophosphamide and steroids: daily oral low-dose cyclophosphamide administration after failure of pulse intravenous high-dose regimen in four patients. Br J Rheumatol 33: 959–962, 1994.
Gross WL, Rasmussen N: Treatment of Wegener’s granulomatosis: the view from two non-nephrologists. Nephrol Dial Transplant 9: 1219–1225, 1994.
Boumpas DT, Austin HA III, Vaughan EM, Klfppel JH, Steinberg AD, Yarboro CH, Balow JE: Severe lupus nephritis: controlled trial of pulse methylprednisolone versus two different regimens of pulse cyclophosphamide. Lancet 340: 741–745, 1992.
DeVita S, Neri R, Bombardieri S: Cyclophosphamide pulses in the treatment of rheumatic diseases: an update. Clin Exp Rheumatol 9: 179–193, 1991.
Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis (letter). Ann Intern Med 114: 430–431, 1991.
Haga HJ, D’Cruz D, Asherson R, Hughes GR: Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis. Ann Rheum Dis 51: 885–888, 1992.
Haubitz M, Frei U, Rother U, Brunkhorst R, Koch KM: Cyclophosphamide pulse therapy in Wegener’s granulomatosis. Nephrol Dial Transplant 6: 531–535, 1991.
Kunis CL, Kiss B, Williams G, D’Agati V, Appel GB: Intravenous “pulse” cyclophosphamide therapy of crescentic glomerulonephritis. Clin Nephrol 37: 1–7, 1992.
Pall AA, Luqmani RA, Adu D, Richards N, Howie AJ, Emery P, Michael J, Bacon PA: Controlled trial of pulse cyclophosphamide (PCY) and prednisolone (PP) versus continuous cyclophosphamide (CCY) and prednisolone (CP) in the treatment of systemic vasculitis (abstract). J Am Soc Nephrol 3: 317, 1992.
Pusey CD, Rees AJ, Evans D, Peters DK, Lockwood CM: Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 40: 757–763, 1991.
Cole E, Cattran D, Magil A, Greenwood C, Churchill D, Sutton D, Clark W, Morrin P, Posen G, Bernstein K, Dyck R, and the Canadian Apheresis Study Group: A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. Am J Kidney Dis 20: 261–269, 1992.
Glockner WM, Sieberth HG, Wichmann HE, Backes E, Bambauer R, Boesken WH, Bohle A, Daul A, Graben N, Keller F, Klehr HU, Kohler H, Metz U, Schultz W, Thoenes W, Vlaho M: Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multicenter study. Clin Nephrol 29: 1–8, 1988.
Hind CR, Paraskevakou H, Lockwood CM, Evans DJ, Peters DK, Rees AJ: Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis. Lancet 1: 263–265, 1983.
Pinching AJ, Rees AJ, Pussell BA, Lockwood CM, Mitchison RS, Peters DK: Relapses in Wegener’s granulomatosis: the role of infection. Br Med J 281: 836–838, 1980.
Weiss DJ, Greenfield JW Jr, O’Rourke KS, McCune WJ: Systemic cytomegalovirus infection mimicking an exacerbation of Wegener’s granulomatosis. J Rheumatol 20: 155–157, 1993.
DeRemee RA: The treatment of Wegener’s granulomatosis with trimethaprim-sulfamethoxazole: illusion or vision? Arthritis Rheum 31: 1068–1074, 1988.
Valeriano-Marcet J, Spiera H: Treatment of Wegener’s granulomatosis with sulfamethoxazole—trimethaprim. Arch Intern Med 151: 1649–1652, 1991.
Boumpas DT, Austin HA, Vaughan EM, Yarboro CH, Klippel JH, Balow JE: Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119: 366–369, 1993.
Baker GL, Kahl LE, Zee BC, Stolzer BL, Agarwal AK, Medsger TA: Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Am J Med 83: 1–9, 1989.
Levy M, Broyer M, Habib R: Pathology and immunopathology of Schönlein—Henoch glomerulonephritis. In: P Kincaid-Smith, AJF d’Apice, RC Atkins, eds, Progress in Glomerulonephritis. John Wiley and Sons, New York, p 261, 1979.
Kauffmann RH, Herrmann WA, Meyer CJ, Daha MR, Van Es LA: Circulating IgA-immune complexes in HenochSchönlein purpura. A longitudinal study of their relationship to disease activity and vascular deposition of IgA. Am J Med 69: 859–866, 1980.
Meadow SR: The prognosis of Henoch Schoenlein nephritis. Clin Nephrol 9: 87–90, 1978.
Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantier C: Prognosis of Henoch—Schönlein nephritis in children. Br Med J 2: 11–14, 1977.
Ilan Y, Naparstek Y: Schönlein—Henoch syndrome in adults and children. Semin Arthritis Rheum 21: 103–109, 1991.
Cameron JS: The nephritis of Schönlein—Henoch purpura: current problems. In: P Kincaid-Smith, AJF d’Apice, RC Atkins, eds, Progress in Glomerulonephritis. John Wiley and Sons, New York, p 283, 1979.
Hall RP, Lawley TJ, Heck JA, Katz SI: IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch—Schönlein purpura, systemic lupus erythematosus and other diseases. Clin Exp Immunol 40: 431–437, 1980.
Fogazzi GB, Pasquali S, Moriggi M, Casanova S, Damilano I, Mihatsch MJ, Zucchelli P, Ponticelli C: Long-term outcome of Schonlein-Henoch nephritis in the adult. Clin Nephrol 31: 60–66, 1989.
Austin HA III, Balow JE: Henoch—Schönlein nephritis: prognostic features and the challenge of therapy. Am J Kidney Dis 2: 512–520, 1983.
Lee HS, Koh HI, Kim MJ, Rha HY: Henoch—Schoenlein nephritis in adults: a clinical and morphological study. Clin Nephrol 26: 125–130, 1986.
Goldstein AR, White RHR, Akuse R, Chantier C. Longterm follow-up of childhood Henoch—Schönlein nephritis. Lancet 339: 280–282, 1992.
Hurley RM, Drummond KN: Anaphylactoid purpura nephritis: clinicopathological correlations. J Pediatr 81: 904911, 1972.
White RH, Cameron JS, Trounce JR. Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome. Br Med J 2: 853860, 1966.
Michael AF, Vernier RL, Drummond KN, Levitt JI, Herdman RC, Fish AJ, Good RA: Immunosuppressive therapy of chronic renal disease. N Engl J Med 276: 817–828, 1967.
Medical Research Council Working Party: Controlled trial of azathioprine and prednisone in chronic renal disease. Br Med J 2: 239–241, 1971.
Fillastre JP, Morel-Maroger L, Richet G: Schönlein—Henoch purpura in adults. Lancet 1: 1243–1244, 1971.
Brown CB, Wilson D, Turner D, Cameron JS, Ogg CS, Chantier C, Gill D: Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis. Lancet 2: 1166–1172, 1974.
Cameron JS, Gill D, Turner DR, Chantier C, Ogg CS, Vosnides G, Williams DG: Combined immunosuppression and anti-coagulation in rapidly progressive glomerulonephritis. Lancet 2: 923–925, 1975.
Rose GM, Cole BR, Robson AM: The treatment of severe glomerulopathies in children using high dose intravenous methylprednisolone pulses. Am J Kidney Dis 1: 148–156, 1981.
McKenzie PE, Taylor AE, Woodroffe AJ, Seymour AE, Chan YL, Clarkson AR: Plasmapheresis in glomerulonephritis. Clin Nephrol 12: 97–108, 1979.
Kauffmann RH, Houwert DA: Plasmapheresis in rapidly progressive Henoch—Schoenlein glomerulonephritis and the effect on circulating IgA immune complexes. Clin Nephrol 16: 155–160, 1981.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Balow, J.E., Austin, H.A. (1998). Vasculitic Diseases of the Kidney. In: Suki, W.N., Massry, S.G. (eds) Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6632-5_29
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6632-5_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6634-9
Online ISBN: 978-1-4757-6632-5
eBook Packages: Springer Book Archive